These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16048913)

  • 1. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
    Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria.
    Cochrane SA; Li X; He S; Yu M; Wu M; Vederas JC
    J Med Chem; 2015 Dec; 58(24):9779-85. PubMed ID: 26636619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin: an update on the antibiotic of the 21st century.
    Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
    Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
    Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B: similarities to and differences from colistin (polymyxin E).
    Kwa A; Kasiakou SK; Tam VH; Falagas ME
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ; Jo J; Kim J; Ko KS; Lee W
    Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis.
    Ruzaimi MY; Shahril Y; Masbah O; Salasawati H
    Med J Malaysia; 2006 Feb; 61 Suppl A():21-6. PubMed ID: 17042224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
    Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity.
    Katsuma N; Sato Y; Ohki K; Okimura K; Ohnishi K; Sakura N
    Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):332-6. PubMed ID: 19336926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy.
    Zavascki AP; Girardello R; Magagnin CM; Antochevis LC; Maciel RA; Palmeiro JK; Gales AC
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):134-138. PubMed ID: 29150371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
    Vaara M
    Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel des-fatty acyl-polymyxin B derivatives with Pseudomonas aeruginosa-specific antimicrobial activity.
    Sato Y; Shindo M; Sakura N; Uchida Y; Kato I
    Chem Pharm Bull (Tokyo); 2011; 59(5):597-602. PubMed ID: 21532197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.